CADILA HEALTHCARE LTD. - Zydus Cadila gets 180-day exclusivity for Nelarabine injection, announces final approval from USFDA

18 Nov 2021

Cadila Healthcare Ltd has informed BSE regarding a Press Release dated November 18, 2021 titled "Zydus Cadila gets 180-day exclusivity for Nelarabine injection, announces final approval from USFDA".

Source: BSE India

View all announcements for CADILA HEALTHCARE LTD.

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist